The pathophysiology of functional dyspepsia (FD) remains unknown. Duodenal eosinophil infiltration has been reported.
SUMMARY Background
The pathophysiology of functional dyspepsia (FD) remains unknown. Duodenal eosinophil infiltration has been reported.
Aim
To assess the association between dyspeptic symptoms and duodenal eosinophilia in children undergoing upper gastrointestinal endoscopy.
Methods
In this retrospective cohort study, children with normal upper endoscopy and routine histology at a single tertiary paediatric centre between 2010 and 2014 were included. FD was defined as epigastric pain or discomfort >2 months without response to acid suppression. Controls presented with nonerosive reflux disease, dysphagia or rumination syndrome. Intramucosal eosinophil counts were compared between the groups using uni-and multivariate regression analyses.
Results
Thirty-six cases and 36 nonmatched controls were identified. Atopic history (39% vs. 25%) and psychological comorbidity (53% vs. 39%; both P = 0.2) were frequent in cases and controls. Self-reported nausea (64% vs. 17%; P < 0.0001), lethargy (19% vs. 0%; P = 0.005) and family functional gastrointestinal disorder(FGID) (28% vs. 3%; P = 0.003) were more common in cases than controls. Duodenal eosinophil counts [median (IQR): 151 (118-207) vs. 76 (60-106) per mm 2 ; P < 0.001] were significantly higher in cases than controls with >112 eosinophils per mm 2 predictive for FD (OR: 33.6, 95% CI: 7.1-159.0; P < 0.001). Duodenal eosinophilia was associated with weight loss (OR: 7.1, 95% CI: 1.1-45.5; P = 0.04).
Conclusions
Functional dyspepsia in children is strongly associated with duodenal eosinophilia, in the absence of endoscopic or routine histological findings. 
INTRODUCTION
Functional dyspepsia (FD) is a common functional gastrointestinal disorder (FGID) that affects children and adults. 1, 2 The reported prevalence of FD in children is 2% and FD leads to substantial healthcare utilisation and frequent school absenteeism. 3 Paediatric hospital discharges for FGID in the USA have increased in cost and frequency, with FD being as common as irritable bowel syndrome (IBS) as a cause of hospital admission. 4 Symptoms include recurrent upper abdominal pain or discomfort, fullness and early satiety, which may be associated with bloating or nausea. 1 Although organic disease must be excluded, the presence of mild and chronic inflammatory changes on biopsies in abdominal pain predominant FGID do not preclude the diagnosis as the significance is uncertain.
2
Several pathophysiologic mechanisms in FD, including delayed impaired gastric emptying or accommodation, hypersensitivity to duodenal lipid or acid exposure, abnormal duodeno-jejunal motility and visceral hypersensitivity have been proposed. [5] [6] [7] [8] In addition, psychological distress such as anxiety and depression is associated with children with FD having lower quality of life scores and morbidity progressing into early adulthood. 9 Duodenal eosinophilia was observed in 71-95% of paediatric FD patients 10, 11 , but whether this represents true pathology is yet to be confirmed. Duodenal eosinophilia has also been observed in adult studies but the significance is also controversial. [12] [13] [14] Eosinophils connect innate and adaptive immune systems and a shift from a Th1 to a Th2-mediated response has been proposed after enteric infection or allergen exposure. 15, 16 Duodenal eosinophilia has been observed in atopic patients and the prevalence of FD in asthma and allergic rhinitis is greater than in control patients in a primary care setting. 17 In children with FD, a therapeutic effect of montelukast, an eosinophil stabilising drug, suggests a potential pathophysiological role, 18, 19 however confirmatory studies are lacking. We sought to determine if duodenal eosinophilia is associated with paediatric FD and study the associations with symptom subgroups. The primary aim of this study was to examine demographic, clinical and histological variables in children with a clinical diagnosis of FD and normal endoscopy and pathology reports compared to controls. The secondary aim was to determine associations between clinical variables and duodenal eosinophil counts. Finally, predictive factors for FD were estimated.
METHODS

Patient population
In this retrospective cohort study, all eligible children (4-18 years old) were identified from the paediatric gastroenterology endoscopy database. Patients younger than 4 years of age were excluded, minimising the influence of potential cow's milk allergy and allowing reliable symptom scoring. Potential subjects had undergone upper gastrointestinal (GI) endoscopy at a single tertiary referral centre between 2010 and 2014 with normal macroscopic findings and no abnormalities on routine histological analysis. Indications for upper GI endoscopy were the exclusion of organic disease. Exclusion criteria included the use of leukotriene receptor antagonists (LTRA) or corticosteroids in the last month and/or histamine H2-receptor antagonists in the last 2 weeks before the endoscopic procedure. Additional exclusion criteria were conditions associated with eosinophilia, including inflammatory bowel disease, coeliac or connective tissue disease, vasculitis, hypereosinophilia, active infection (parasites and Helicobacter-like organisms on biopsies or positive stool cultures) and transplantation. Current medication use including proton pump inhibitors (PPI) at the time of endoscopy was assessed through review of admission records. Gender, age at time of endoscopy, patient race, personal and family history of gastrointestinal, atopic and psychological comorbidity were assessed through review of medical records. The Hunter New England Human Research Ethics Committee approved the study protocol (13/04/17/5.10).
Cases and controls
Cases were patients with a diagnosis of FD, which was defined following Rome III criteria as epigastric pain or discomfort that was not relieved by defecation or associated with a change in stool pattern. 2 Children were eligible if symptoms persisted for more than 2 months with or without symptoms of reflux and/or retrosternal burning and with no clinical response to a trial of acid suppression therapy. The indication for upper GI endoscopy was the exclusion of organic disease and children were only included in the absence of endoscopic and routine histological findings. Cases were subdivided according to the presence of any pain (located in the epigastrium or upper abdomen and retrosternal or chest pain) and/or discomfort (defined as sickness, early satiety, post-prandial fullness or bloating), with both symptoms not being mutually exclusive. Controls were children with diagnosis of nonerosive reflux disease (NERD), adolescent rumination syndrome or nonorganic dysphagia in the absence of epigastric symptoms suggestive of (overlapping) FD after normal upper GI endoscopy, also performed for the exclusion of organic pathology.
Endoscopy and H. pylori infection
Upper gastrointestinal endoscopy with biopsies was performed at the John Hunter Children's Hospital (Newcastle, NSW, Australia) after obtaining informed patient or parent/guardian consent by a single paediatric gastroenterologist (SN). The presence of oesophageal, gastric or duodenal changes was routinely assessed with routine biopsies taken at three sites (distal oesophagus, gastric antrum and second duodenum). The presence of H. pylori was assessed on antral biopsies using Giemsa staining in all patients, with additional urease testing in case of macroscopic abnormalities. Only patients with normal endoscopy reports, that is,. no ulcer disease or reflux oesophagitis, were included.
Histology and eosinophil counts
Sections of formalin fixed, paraffin embedded and haematoxylin and eosin stained mucosal biopsies were re-evaluated for intramucosal eosinophils counts per high-power field (HPF) for oesophageal and per mm 2 for gastric and duodenal biopsies using the Aperio AT2 scanner (Leica Biosystems, Victoria, VIC, Australia). Scanned slides were numbered independent of pathology and/or year of endoscopy, blinding the pathologists (BS/ MW) to patient status. Mucosal eosinophils were quantified by randomly selecting villous and submucosal sections without Brunner's glands for duodenal biopsies. Duodenal intra-epithelial lymphocyte (IEL) counts were also counted per 100 enterocytes and lymphocytic duodenosis (LD) defined by normal duodenal architecture and ≥25 IELs per 100 enterocytes. 20 
Statistical analysis
Categorical data were summarised as percentages and continuous data as means plus standard deviation (SD) for parametric or medians plus interquartile ranges (IQR) for nonparametric variables. Categorical data were analysed using chi-sqaure and Fisher's exact tests when appropriate and continuous data using Student's t for parametric and Mann-Whitney U tests for nonparametric variables. Univariate analyses of clinical, demographic and histological variables between FD cases and controls were performed using Prism GraphPad Software (La Jolla, CA, USA). Multivariate regression analysis with calculation of odds ratio's (OR) for variables with duodenal eosinophil counts greater than the median (151 per mm 2 ), controlling for age, gender and current PPI were performed using STATA v13.0 (College Station, TX, USA). Finally, predictive factors of FD were analysed with demographic and clinical variables significantly associated with FD from the univariate analysis and with duodenal eosinophil counts as dichotomous variable after computing a receiver-operator characteristics (ROC) curve and identifying the cut-off with maximal sensitivity and specificity. All P-values were two-tailed with significance set at 0.05.
RESULTS
Patient selection
Of 76 patients with normal endoscopy and histopathology reports, 36 cases and 36 nonmatched controls were identified after exclusion of patients with missing duodenal biopsies (n = 4). Dyspeptic symptoms were predominantly epigastric pain in 81% and/or upper abdominal discomfort in 33% and were reported as post-prandial in 69% and sleep-interrupting in 31%. In controls, 53% were identified with NERD, 33% with nonorganic dysphagia and 14% with adolescent rumination syndrome.
Clinical analysis
There was a similar majority of females (56% vs. 53%; P = 0.81) and mean (AEs.d.) age was slightly higher in cases compared to controls (13.6 (AE3.1) vs. 10.5 (AE4) years; P = 0.001). Most of the patients were Caucasian (89% in cases and controls), with indigenous Australians in three cases and four controls and one Pacific Islander in FD. Personal atopic history of eczema (14% vs. 8%; P = 0.45), asthma (17% vs. 14%; P = 0.74) and/or allergic rhinitis (22% vs. 17%; P = 0.55) was similar in cases and controls (total 39% vs. 25%; P = 0.21). Psychological history (53% vs. 39%; P = 0.24) was also similar in cases compared to controls. Family history of FGID (28% vs. 3%; P < 0.01), self-reported nausea (64% vs. 17%; P < 0.0001) and lethargy (19% vs. 0%; P < 0.01) were more common in FD than controls. There were no differences in other clinical variables at the time of endoscopy between cases and controls (Table 1) .
Histological analysis
Median (IQR) duodenal eosinophil counts [151 (118-207) vs. 76 (60-106) per mm 2 ; P < 0.001] were significantly increased in cases as compared to controls (Figure 1) . Duodenal IEL counts [10 (8-13) vs. 12 (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) per 100 enterocytes; P = 0.12] were similar ( Figure 1 (Table 3 ). The cut-off value for duodenal eosinophilia was derived from the ROC curve with the maximal sensitivity and specificity (83% for each, c-statistic 0.92) (Figure 2 ).
DISCUSSION
The present study applying blinded histological review identified duodenal eosinophilia in children with FD compared to controls despite the histology being reported as "normal" in the routine clinical setting. Moreover, a duodenal eosinophil count of over 112 per mm 2 was associated with a 33 fold increased risk of FD after adjusting for potential confounders such as age, gender and PPI use. FD cases were slightly older and complained more frequently of nausea and fatigue compared to controls. Family history of FGID was more common in FD. Although atopic and psychological comorbidity was frequent in FD, the prevalence was not significantly greater than in controls. Weight loss was associated with duodenal eosinophilia. This is the first study to confirm excess duodenal eosinophilia in paediatric FD.
Duodenal eosinophilia has been noted to be more frequent in allergic patients, 13 however, no difference in atopy was evident in adult FD. 14 In the present study, atopy was common in FD but not associated with duodenal eosinophilia when controlling for age, gender and current PPI use. This suggests nonallergic mechanisms of eosinophilic inflammation may play a role in FD. In both adult 21 and paediatric FD, 9, 22 anxiety was more common in postprandial distress syndrome (PDS), but not the epigastric pain syndrome. As duodenal eosinophilia in adults is linked to PDS, this suggests an interaction between psychological distress and duodenal eosinophilia. 23 Despite the high rates of psychological comorbidity in our cohort, we did not find this factor to be associated with FD or duodenal eosinophilia when controlling for age, gender and current PPI use. Associations with psychological comorbidities in other studies may relate to an increased prevalence in patients presenting with GI symptoms in general, rather than an underlying role in the pathophysiology. 24 Duodenal eosinophilia was associated with weight loss, and a subset of adults with dyspepsia in the community also experience weight loss. 23 Other data suggest adults with FD and fundic dysaccommodation are more likely to be unable to finish a normal sized meal and may then lose weight or be underweight. 25 Duodenal eosinophilia may be associated with more severe symptoms and weight loss, or motility disturbances such as fundic dysaccommodation via intestino-gastric reflexes or other mechanisms. Diagnosis based on symptoms alone does not reliably distinguish between organic and functional causes of dyspepsia and many patients with chronic dyspeptic symptoms undergo endoscopy to rule out organic disease. 25 Based on this and previous studies, the routine histological examination should include duodenal eosinophil counts in FD. The absence of eosinophils in oesophageal or gastric biopsies in the present study point to the duodenum as the key region of interest. Impaired duodenal epithelial integrity and low-grade inflammation with predominant eosinophils and mast cells were reported in the mucosa and submucous ganglion plexus of adult FD patients. 26, 27 The barrier defect may be caused by stress, food or microbial components and incite an immune response to luminal antigens with alterations of neuronal function. 28 The therapeutic effect of montelukast was unrelated to changes in eosinophil Bold values are significant. density or activation in a controlled paediatric trial, suggesting this effect may have been neuronally mediated. 19 Although small bowel permeability was found to be similar in paediatric FD and not related to mast cell and eosinophil densities, the inflammatory changes limited to the duodenum might only influence more sensitive measures of permeability. 29 The pathophysiology of FD remains incompletely understood and future studies including measures of eosinophil degranulation and targeting the inflammatory response are required. We also assessed duodenal intra-epithelial lymphocyte (IEL) counts. Only four patients with LD were identified (all controls) of which none had diarrhoea and only one had coeliac testing which was negative. Duodenal IEL counts were not significantly different between cases and controls in an adult FD study.
14 LD, while heralding coeliac disease (CD) in some adults and children, is associated with gastrointestinal and other disease [30] [31] [32] [33] [34] but not FD in the present study. In Finnish children, LD was a poor predictor of progression to CD over long-term follow-up. 32 The ESPGHAN guidelines for the diagnosis of CD in children and adolescents recommend that LD cases (>25 IELs per 100 enterocytes) require additional supportive evidence (serological, genetic and histological) and exclusion of other diseases which may cause these changes, before establishing the diagnosis of CD. 35 In a paediatric cohort from the Mayo Clinic, LD was present in 4.3% of duodenal biopsies and associated with CD in 9%, drugs in 17%, inflammatory bowel disease in 9% and H. pylori in 5%. 30 The strengths of this study include the clinically well-characterised subjects with evaluation of dyspeptic symptoms and management by a single paediatric gastroenterologist, allowing uniform diagnosis and data recording. A separate investigator verified the clinical notes and diagnostic criteria for FD. Pathologists blinded to patient status performed eosinophil counts in a standardised fashion per HPF in the oesophagus (as for eosinophilic oesophagitis) and per mm 2 in the duodenum and excluding Brunner's glands, as differences in density and degranulation between D1 and D2 may exist. 12, 14 The limitations are the study size, and lack of formal exclusion of intestinal infection by stool culture, which could have explained some of the duodenal changes. 36 However, intestinal infections typically do not present with isolated upper gastrointestinal symptoms and patients did not have lower gastrointestinal symptoms. Moreover, antral biopsies were assessed for Helicobacter-like organisms and duodenal biopsies for visible pathogens. Additional testing of H. pylori was not considered necessary in the absence of suggestive microscopic changes (such as histological gastritis) and H. pylori in Australian children is now rare. 37 The similar racial distribution in cases and controls also minimises the potential influence of diet and/or enteric infections on duodenal eosinophil counts. Although comparison with healthy controls would be ideal, ethical considerations regarding subjecting healthy children to endoscopy would not make this possible. Controls without epigastric symptoms and indications for endoscopy that were unlikely to be associated with duodenal pathology were selected. Data on remote use of medications that may influence duodenal eosinophil counts was not available and although a number of NERD patients may have had previous PPI use, current PPI use was not different between cases and controls. Finally, inclusion of patients with presumed FD undergoing upper endoscopy may imply selection bias, as endoscopy may have been reserved for patients with more severe or persistent symptoms.
In conclusion, duodenal eosinophilia is common in paediatric FD and may potentially alter the current diagnostic approach with implications for therapy if confirmed in further and larger studies in both children and adults. The potential role of duodenal eosinophils in the pathophysiology of FD requires further investigation, including elucidation of mechanisms of eosinophil recruitment and activation, association with functional studies such as manometry and gastric accommodation, and evaluation of targeted therapies.
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